The levels of serum VEGF in patients with NSCLC was also higher than those of healthy controls (512.26 ± 110.58 pg/ml vs. 388.56 ± 123.67 pg/ml, p < 0.05, Figure 1B, Table 1). Here, VEGFA is linked to non-small cell lung carcinoma.